MRK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Stats
Dagens volum	6.44M
Gjennomsnittsvolum	8.41M
Markedsverdi	329.55B
EPS	$0.0300 ( 2024-04-25 )
Neste inntjeningsdato	( $1.870 ) 2024-05-28
Last Dividend	$0.770 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	142.99
ATR14	$0.0790 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Larson Betty D	Buy	0
2024-03-28	Wendell Peter C	Buy	227	Phantom Stock
2024-03-28	Seidman Christine E	Buy	62	Phantom Stock
2024-03-28	Glocer Thomas H	Buy	341	Phantom Stock
2024-03-28	Coe Mary Ellen	Buy	227	Phantom Stock

INSIDER POWER
-14.95
Last 97 transactions
Buy: 664 150 \| Sell: 957 668

Volum Korrelasjon

Lang: 0.22 (neutral)

Kort: 0.34 (neutral)

Signal:(71.563) Neutral

Merck & Co Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Merck & Co Inc Korrelasjon - Valuta/Råvare

-0.31
( neutral )

-0.33
( neutral )

0.00
( neutral )

-0.01
( neutral )

-0.86
( strong negative )

0.21
( neutral )

Merck & Co Inc Økonomi

Annual	2023
Omsetning:	$59.87B
Bruttogevinst:	$43.89B (73.31 %)
EPS:	$0.140

FY	2023
Omsetning:	$59.87B
Bruttogevinst:	$43.89B (73.31 %)
EPS:	$0.140

FY	2022
Omsetning:	$59.28B
Bruttogevinst:	$41.87B (70.63 %)
EPS:	$5.73

FY	2021
Omsetning:	$48.70B
Bruttogevinst:	$35.08B (72.02 %)
EPS:	$5.16

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.690 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.770 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Merck & Co Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.64 - Stable (7.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00663	1970-06-02
Last Dividend	$0.770	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-08
Next Payout Date	N/A
# dividends	214	--
Total Paid Out	$52.58	--
Avg. Dividend % Per Year	2.07%	--
Score	5.72	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.64
Div. Directional Score	7.97	--

Next Divdend (Est)
(2024-07-08)

$0.776 Estimate 39.86 %

Dividend Stability

0.80 Good

Dividend Score

5.72

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1970	$0.0206	1.40%
1971	$0.0292	2.31%
1972	$0.0224	1.35%
1973	$0.0327	1.36%
1974	$0.0278	1.31%
1975	$0.0371	2.09%
1976	$0.0378	2.04%
1977	$0.0411	2.31%
1978	$0.0465	3.27%
1979	$0.0530	2.94%
1980	$0.0628	3.34%
1981	$0.0702	3.08%
1982	$0.0744	3.28%
1983	$0.0757	3.39%
1984	$0.0809	3.37%
1985	$0.0875	3.54%
1986	$0.106	2.90%
1987	$0.143	2.14%
1988	$0.208	2.38%
1989	$0.274	3.01%
1990	$0.321	2.57%
1991	$0.378	2.66%
1992	$0.458	1.73%
1993	$0.506	2.42%
1994	$0.554	3.29%
1995	$0.610	3.34%
1996	$0.706	2.30%
1997	$0.830	2.18%
1998	$0.946	1.84%
1999	$1.070	1.50%
2000	$1.202	1.86%
2001	$1.316	1.48%
2002	$1.356	2.38%
2003	$4.14	7.45%
2004	$1.432	3.19%
2005	$1.452	4.87%
2006	$1.452	4.65%
2007	$1.452	3.46%
2008	$1.452	2.65%
2009	$1.452	4.91%
2010	$1.452	4.11%
2011	$1.490	4.33%
2012	$1.613	4.41%
2013	$1.650	4.18%
2014	$1.689	3.58%
2015	$1.726	3.16%
2016	$1.765	3.52%
2017	$1.802	3.14%
2018	$1.899	3.54%
2019	$2.16	2.99%
2020	$2.37	2.69%
2021	$2.61	3.38%
2022	$2.80	3.64%
2023	$2.96	2.66%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0376	1.500	9.25	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0216	1.200	9.28	10.00	[0 - 0.3]
returnOnEquityTTM	0.0561	1.500	-0.488	-0.731	[0.1 - 1]
payoutRatioTTM	3.23	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.252	0.800	8.74	6.99	[1 - 3]
quickRatioTTM	0.710	0.800	-0.532	-0.425	[0.8 - 2.5]
cashRatioTTM	0.269	1.500	9.62	10.00	[0.2 - 2]
debtRatioTTM	0.331	-1.500	4.48	-6.72	[0 - 0.6]
interestCoverageTTM	8.10	1.000	8.11	8.11	[3 - 30]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.60	2.00	8.20	10.00	[0 - 20]
debtEquityRatioTTM	0.940	-1.500	6.24	-9.36	[0 - 2.5]
grossProfitMarginTTM	0.762	1.000	0.627	0.627	[0.2 - 0.8]
operatingProfitMarginTTM	0.119	1.000	9.61	9.61	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.368	1.000	9.07	9.07	[0.2 - 2]
assetTurnoverTTM	0.576	0.800	9.50	7.60	[0.5 - 2]
Total Score				11.29

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	144.31	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0561	2.50	-0.313	-0.731	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.60	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.29	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	3.23	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-1.547	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.212	1.000	7.20	0	[0.1 - 0.5]
Total Score				4.64

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.